|
Bioaffinity Technologies Inc (NASDAQ: BIAF) |
|
Bioaffinity Technologies Inc
BIAF's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Bioaffinity Technologies Inc growth rates, revenue grew
by 687.44 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 16
Medical Laboratories industry recorded
growth of revenues by 6.58 %
Bioaffinity Technologies Inc net loss decreased from $-2 millions, to $-2 millions in III. Quarter 2024,
• More on BIAF's Growth
|
|
Bioaffinity Technologies Inc realized a net loss in trailing twelve months.
Bioaffinity Technologies Inc realized cash reduction of $ -0.3 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.94.
Medical Laboratories industry's Price to Sales ratio is at 2.52.
• More on BIAF's Valuation
|
|
|
|
|
Bioaffinity Technologies Inc realized net loss in trailing twelve months.
Bioaffinity Technologies Inc realized cash outflow of $ -0.3per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.94.
Medical Laboratories industry's Price to Sales ratio is at 2.52.
Bioaffinity Technologies Inc Price to Book Ratio is at 2.82 lower than Industry Avg. of 29.56. and higher than S&P 500 Avg. of 0.01
• More on BIAF's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com